Research News and Research

RSS

Exposure to persistent organic pollutants alters cortisol level in blood

Karin E Zimmer's PhD research shows that persistent organic pollutants (POPs), such as PCB and mixtures of different POPs, affect the way the adrenal cortex functions and thereby the synthesis of the stress hormone cortisol.

28 Dec 2010

Sinovac's inactivated EV71 vaccine clinical trial against HFMD receives Chinese SFDA approval

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it received approval from the China State Food and Drug Administration (SFDA) to commence clinical trials for its proprietary inactivated EV71 vaccine against Hand, Foot and Mouth Disease (HFMD).

28 Dec 2010

Warburg Pincus affiliates to acquire ReSearch Pharmaceutical Services for $6.10 per share

ReSearch Pharmaceutical Services, Inc. (RPS) announced today it has entered into an agreement to sell the company to affiliates of Warburg Pincus, LLC, the global private equity firm, in an all cash transaction valued at $6.10 per share. The Board of Directors of RPS unanimously approved the acquisition agreement and recommended that RPS shareholders approve the transaction. It is presently anticipated that closing of the transaction will occur in February 2011.

28 Dec 2010

Alcohol worries

Festival season usually means excessive and binge drinking leading to accidents and other health concerns say experts. With the outrage of anti-alcohol groups laws may be tightened but many experts feel that it is not the alcohol that needs to be focused on but the people who over-indulge.

28 Dec 2010

BIOMICs oversees SGIker DNA Bank to know genetic heritage of Basque lineage

The BIOMICs Group, based at the Lucio Lascaray building in the álava/Araba campus of the University of the Basque Country, is specially known for overseeing the SGIker DNA Bank, not only undertaking this task, but also feeding data into the gene research bank and making good use of it for their own lines of research.

28 Dec 2010

Met-FISC complex formation critical step in juvenile hormone signaling pathway

Just as raging hormones are part of the process of a child's maturation through the teen years to adulthood, juvenile hormones, a group of insect isoprenoids, play an important role as butterflies, fruit flies and mosquitoes transform their body structures as they molt from larva to pupa and then adults.

28 Dec 2010

UPMC MyHealth Connect web-browser mobile application launched

UPMC Health Plan is introducing UPMC MyHealth Connect, its first web-browser mobile application and the first in the region to provide access to all members and non-members regardless of the brand of smartphone they use. MyHealth Connect will provide most users with immediate access to UPMC Health Plan's network of doctors, hospitals, facilities and urgent care centers.

28 Dec 2010

Mayo Clinic introduces Beanie Baby plush toy

Mayo Clinic announces the sale of a Beanie Baby® plush toy depicting Dr. Jack, canine hero of the recently published children's book, "Let's Visit Mayo Clinic with Dr. Jack the Helping Dog."

28 Dec 2010

International reference standards for use of bone turnover markers in clinical studies recommended

An expert working group of the International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) has released a new position paper which reviews the evidence of bone turnover markers (BTMs) in fracture risk prediction and monitoring of osteoporosis therapy. More importantly, it identifies research priorities and recommends that specific markers be used as reference analytes for BTMs in clinical and observational studies.

28 Dec 2010

Intellect obtains pharmacokinetic data from OX1 Phase 1b trial for Alzheimer's disease

Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has obtained a draft pharmacokinetic report from its completed Phase 1b trial for its lead Alzheimer's candidate, OX1. The Company previously reported on the safety aspects of the trial, which demonstrated that OX1 is safe and well tolerated at all dose levels tested.

28 Dec 2010

Epilepsy not getting the public attention and research funding it deserves

Epilepsy, a common and serious neurologic disorder that affects millions of people, is not getting the public attention and funding for research it deserves, according to an editorial on a study published in the January 4, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.

28 Dec 2010

ACT, Roslin Cells collaborate to establish hESC line bank using single-ceblastomere technique

Advanced Cell Technology, a leader in the field of regenerative medicine, announced today that it has entered into a Memorandum of Understanding with Roslin Cells LTD of Scotland, in which the two companies contemplate a definitive collaboration agreement in the near future.

28 Dec 2010

U.S judge awards $11.7 million to DF/HCC for large-scale prostrate cancer research

Dana Farber/Harvard Cancer Center will launch a new multi-million dollar grant award program focused on prostate cancer research. It will be administered in collaboration with the Prostate Cancer Foundation.

28 Dec 2010

Study sheds light on how bacteria developed resistance to antibiotics

Studying how bacteria incorporate foreign DNA from invading viruses into their own regulatory processes, Thomas Wood, professor in the Artie McFerrin Department of Chemical Engineering at Texas A&M University, is uncovering the secrets of one of nature's most primitive immune systems.

27 Dec 2010

First “saviour sibling” procedure successful

In a first, a nine year old girl received tissue donated by her 18-month old brother Max who was created specifically so that he could aid her medical treatment – a procedure termed as “savior sibling”. This is the first time that the procedure has been under the supervision of British researchers from IVF onwards.

27 Dec 2010

Cancer survival rates improving

Survival rates for cancers of the bowel, breast, lung and ovary that were diagnosed between 1995 and 2007 were compared between Australia, Canada, Denmark, Norway, Sweden and the UK. Overall, survival rates improved in all six countries. However, survival was found to be “persistently lower” in Denmark, England, Northern Ireland and Wales. This was particularly the case after the first year of diagnosis and for patients aged 65 and over. In UK cancer survival rates have improved significantly. Breast cancer survival at five years, for example, increased from 74.8% in 1995-9, to 81.6% in 2005-7. Despite this, the UK still has the lowest breast cancer survival rate at five years.

27 Dec 2010

Stress may boost memory: Study

In a new study researchers have found that stress can enhance ordinary, unrelated memories. This may open up new avenues in management of patients of post-traumatic stress disorder (PTSD) and related afflictions say experts.

27 Dec 2010

Placebos work

According to a new study people who knowingly take a dummy pill or placebo may benefit from it. These pills are usually made from sugar or other inert non-harmful materials. Usually when used in clinical trials patients are unaware whether they are taking the tested drug or a placebo to ensure the medical benefits of a potential new drug are assessed rigorously. However this new study published in the science journal PLoS ONE, found placebos may work even when patients are aware that they are taking them.

27 Dec 2010

New findings may solve mystery about how starvation hormone affects multiple biological systems

New findings by UT Southwestern Medical Center researchers may solve a 17-year-old mystery about how the so-called "starvation hormone" affects multiple biological systems, including preventing insulin sensitivity and promoting cell survival.

27 Dec 2010

Exiqon announces introduction of GLP compliant services for miRNA biomarker screening

Exiqon A/S, a leading provider of technologies for biomarker detection, today announced the introduction of GLP compliant services for miRNA biomarker screening and diagnostic assay development for clinical trials.

27 Dec 2010

Research News and Research

Exposure to persistent organic pollutants alters cortisol level in blood

Sinovac's inactivated EV71 vaccine clinical trial against HFMD receives Chinese SFDA approval

Warburg Pincus affiliates to acquire ReSearch Pharmaceutical Services for $6.10 per share

Alcohol worries

BIOMICs oversees SGIker DNA Bank to know genetic heritage of Basque lineage

Met-FISC complex formation critical step in juvenile hormone signaling pathway

UPMC MyHealth Connect web-browser mobile application launched

Mayo Clinic introduces Beanie Baby plush toy

International reference standards for use of bone turnover markers in clinical studies recommended

Intellect obtains pharmacokinetic data from OX1 Phase 1b trial for Alzheimer's disease

Epilepsy not getting the public attention and research funding it deserves

ACT, Roslin Cells collaborate to establish hESC line bank using single-ceblastomere technique

U.S judge awards $11.7 million to DF/HCC for large-scale prostrate cancer research

Study sheds light on how bacteria developed resistance to antibiotics

First “saviour sibling” procedure successful

Cancer survival rates improving

Stress may boost memory: Study

Placebos work

New findings may solve mystery about how starvation hormone affects multiple biological systems

Exiqon announces introduction of GLP compliant services for miRNA biomarker screening

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News